Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

As per Future Market Insights, PSG devices are expected to be the most preferred sleep apnea diagnostic systems during the ...

Signifier Medical secures EU MDR certification for eXciteOSA®, ensuring safety, efficacy, and broader access to its ...

Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...

China: A recent study published in the Journal of the American Heart Association has unveiled a compelling association ...

Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder. Normally, air should flow smoothly from the mouth and nose into the lungs at all times, including during sleep.

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous positive airway pressure (CPAP ...

Turkey: A recent study published in The Laryngoscope revealed a significant relationship between laryngopharyngeal reflux ...

In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...

Healthcare announced the appointment of Alison Wimms, Ph.D. as an advisor to its newly formed IHL-42X Obstructive Sleep Apnea ...